Skip to Content

Committed to Safety: As we resume services, we are taking all necessary precautions to keep you safe while we care for you. Limited visitation is now in place. Review all our visitor policies and precautions. Get more information on COVID-19.

Clinical Trials Details

NRG BR003

Patient Information

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer.

Learn more about clinical trial - NRG BR003

Clinical Trial Categories

  • Breast Cancer - Adjuvant

Location

  • Cone Health Cancer Center at Alamance Regional
    1236 Huffman Mill Rd.
    Burlington, NC 27215
    Main: 336-538-7725
  • Cone Health Cancer Center at Wesley Long
    2400 W. Friendly Avenue
    Greensboro, NC 27403
    Main: 336-832-1100